A. Boonstra

3.7k total citations · 1 hit paper
41 papers, 2.6k citations indexed

About

A. Boonstra is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, A. Boonstra has authored 41 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 11 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in A. Boonstra's work include Pulmonary Hypertension Research and Treatments (28 papers), Cardiovascular Function and Risk Factors (8 papers) and Systemic Sclerosis and Related Diseases (4 papers). A. Boonstra is often cited by papers focused on Pulmonary Hypertension Research and Treatments (28 papers), Cardiovascular Function and Risk Factors (8 papers) and Systemic Sclerosis and Related Diseases (4 papers). A. Boonstra collaborates with scholars based in Netherlands, United States and Italy. A. Boonstra's co-authors include Anton Vonk Noordegraaf, Pieter E. Postmus, Koen Marques, S. A. van Wolferen, Jean G.F. Bronzwaer, Marieke D. Spreeuwenberg, J. Tim Marcus, Nico Westerhof, Richard N. Channick and C. Tji Gan and has published in prestigious journals such as Scientific Reports, Journal of Applied Physiology and European Heart Journal.

In The Last Decade

A. Boonstra

40 papers receiving 2.5k citations

Hit Papers

Prognostic value of right ventricular mass, volume, and f... 2007 2026 2013 2019 2007 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension
    2007 573 citations S. A. van Wolferen, J. Tim Marcus et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Boonstra Netherlands 20 2.3k 1.7k 314 303 261 41 2.6k
David P. Kapelanski United States 25 1.7k 0.8× 1.3k 0.8× 487 1.6× 300 1.0× 163 0.6× 37 2.6k
Anco Boonstra Netherlands 35 3.8k 1.7× 3.3k 2.0× 261 0.8× 689 2.3× 112 0.4× 71 4.5k
Paola Argiento Italy 26 1.7k 0.8× 1.4k 0.9× 97 0.3× 480 1.6× 166 0.6× 60 2.0k
J Niedermeyer Germany 20 1.6k 0.7× 988 0.6× 278 0.9× 183 0.6× 100 0.4× 56 2.1k
Christiana Blair United States 19 1.2k 0.5× 865 0.5× 248 0.8× 135 0.4× 202 0.8× 41 1.6k
Deepa Gopalan United Kingdom 23 1.2k 0.5× 954 0.6× 167 0.5× 199 0.7× 113 0.4× 119 2.1k
C. Tji Gan Netherlands 19 1.7k 0.7× 1.5k 0.9× 76 0.2× 438 1.4× 59 0.2× 48 2.0k
Ioannis Moyssakis Greece 22 354 0.2× 868 0.5× 284 0.9× 367 1.2× 232 0.9× 80 1.8k
P Hervé France 13 1.2k 0.5× 671 0.4× 210 0.7× 309 1.0× 60 0.2× 28 1.7k
Jolene M. Kriett United States 22 846 0.4× 820 0.5× 130 0.4× 175 0.6× 58 0.2× 53 1.6k

Countries citing papers authored by A. Boonstra

Since Specialization
Citations

This map shows the geographic impact of A. Boonstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Boonstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Boonstra more than expected).

Fields of papers citing papers by A. Boonstra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Boonstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Boonstra. The network helps show where A. Boonstra may publish in the future.

Co-authorship network of co-authors of A. Boonstra

This figure shows the co-authorship network connecting the top 25 collaborators of A. Boonstra. A scholar is included among the top collaborators of A. Boonstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Boonstra. A. Boonstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Noël J.C., et al.. (2025). Association of intraocular lens tilt and decentration with visual acuity using SS-OCT-based analysis. Graefe s Archive for Clinical and Experimental Ophthalmology. 263(12). 3423–3432. 1 indexed citations
2.
Boonstra, A., Sophie Leijdesdorff, Cathy Street, et al.. (2024). Turning 18 in mental health services: a multicountry qualitative study of service user experiences and views. Irish Journal of Psychological Medicine. 41(3). 296–304. 2 indexed citations
3.
Smits, Alexander J., Esther J. Nossent, A. Boonstra, et al.. (2024). Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?. Scientific Reports. 14(1). 19467–19467. 1 indexed citations
4.
Boonstra, A., Thérèse van Amelsvoort, Rianne Klaassen, et al.. (2024). Evaluating changes in functioning and psychological distress in visitors of the @ease youth mental health walk-in centres. BJPsych Open. 10(3). e101–e101. 1 indexed citations
5.
Boonstra, A., Ghislaine van Mastrigt, Silvia Evers, Thérèse van Amelsvoort, & Sophie Leijdesdorff. (2023). @ease peer‐to‐peer youth walk‐in centres in The Netherlands: A protocol for evaluating longitudinal outcomes, follow‐up results and cost‐of‐illness. Early Intervention in Psychiatry. 17(9). 929–938. 4 indexed citations
6.
Boonstra, A., Alexandre E. Voskuyl, M.J. Vonk, et al.. (2011). Platelet- derived growth factor receptor-beta and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study. Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam). 2 indexed citations
7.
Knaapen, Paul, Mark Lubberink, Gerrina Ruiter, et al.. (2011). Supine-exercise-induced oxygen supply to the right myocardium is attenuated in patients with severe idiopathic pulmonary arterial hypertension. Heart. 97(24). 2069–2074. 11 indexed citations
8.
Ruiter, Gerrina, Stephanie Lankhorst, A. Boonstra, et al.. (2010). Iron deficiency is common in idiopathic pulmonary arterial hypertension. European Respiratory Journal. 37(6). 1386–1391. 151 indexed citations
9.
Man, Frances S. de, M. Louis Handoko, Herman Groepenhoff, et al.. (2009). Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. European Respiratory Journal. 34(3). 669–675. 159 indexed citations
10.
Overbeek, Maria J., Madelon C Vonk, A. Boonstra, et al.. (2009). Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. European Respiratory Journal. 34(2). 371–379. 118 indexed citations
11.
Overbeek, Maria J., Nico Westerhof, Alexandre E. Voskuyl, et al.. (2008). Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. European Respiratory Journal. 31(6). 1160–1166. 77 indexed citations
12.
Overbeek, Maria J., Geerten P. van Nieuw Amerongen, A. Boonstra, Egbert F. Smit, & Anton Vonk Noordegraaf. (2008). Possible role of imatinib in clinical pulmonary veno-occlusive disease: Fig. 1—. European Respiratory Journal. 32(1). 232–235. 55 indexed citations
13.
Wolferen, S. A. van, J. Tim Marcus, A. Boonstra, et al.. (2007). Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. European Heart Journal. 28(10). 1250–1257. 573 indexed citations breakdown →
14.
Denton, Christopher P., Janet Pope, HH Peter, et al.. (2007). Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. Annals of the Rheumatic Diseases. 67(9). 1222–1228. 108 indexed citations
15.
Szentesi, Péter, Brechje J. van Beek-Harmsen, Willem J. van der Laarse, et al.. (2005). Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure. Journal of Applied Physiology. 99(6). 2189–2195. 37 indexed citations
16.
Noordegraaf, Anton Vonk, S. A. van Wolferen, J. Tim Marcus, et al.. (2005). Noninvasive assessment and monitoring of the pulmonary circulation. European Respiratory Journal. 25(4). 758–766. 21 indexed citations
17.
Humbert, Marc, Robyn J. Barst, Ivan M. Robbins, et al.. (2004). Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. European Respiratory Journal. 24(3). 353–359. 464 indexed citations
18.
Smit, Henk, Anton Vonk Noordegraaf, Roald J. Roeleveld, et al.. (2002). Epoprostenol-induced pulmonary vasodilatation in patients with pulmonary hypertension measured by electrical impedance tomography. Physiological Measurement. 23(1). 237–243. 21 indexed citations
19.
Boonstra, A., et al.. (1988). Factors influencing the quantitative determination of tear proteins by high performance liquid chromatography. Current Eye Research. 7(9). 893–901. 12 indexed citations
20.
Boonstra, A., et al.. (1987). Analysis of human tear protein profiles using high performance liquid chromatography (HPLC). Documenta Ophthalmologica. 67(1-2). 105–113. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David P. Kapelanski Breakdown of academic impact, for papers by Anco Boonstra Breakdown of academic impact, for papers by Paola Argiento Breakdown of academic impact, for papers by J Niedermeyer Breakdown of academic impact, for papers by Christiana Blair Breakdown of academic impact, for papers by Deepa Gopalan Breakdown of academic impact, for papers by C. Tji Gan Breakdown of academic impact, for papers by Ioannis Moyssakis Breakdown of academic impact, for papers by P Hervé Breakdown of academic impact, for papers by Jolene M. Kriett
Rankless by CCL
2026